Cover-Image-Homepage-HIV on macrophage

AIDS 2016: A Return to Durban

To be sure, the progress in providing millions of HIV-infected people with life-saving antiretroviral treatment and the progress in developing new prevention strategies was oft discussed at AIDS 2016. But advocates, public health experts, and government officials are far from resting on their laurels. In fact, experts at AIDS 2016 warned that the hard-won gains against HIV/AIDS are in peril of being lost if financial support isn’t maintained and improved HIV prevention efforts aren’t implemented. In this issue, we provide our complete coverage of AIDS 2016. We also look at how the European Union is hoping to stimulate HIV vaccine research efforts across its partner countries and provide an update on the imminent HVTN 702 trial, the first large-scale vaccine efficacy trial to begin since the results of the RV144 trial in Thailand indicated that a prime-boost vaccine regimen provided a modest 31% protection against HIV infection. Finally, we include an interview with Ugandan physician, public health expert, and former IAVI Board member Alex Coutinho about his long and varied career working in HIV.


Recent Features

Living Positive in Malaysia

HIV GreenQ&A with Andrew Tan, founder and president of myPlus, a network of HIV-positive people in Malaysia. Tan came out in public as an HIV-positive gay man in his speech opening night of IAS 2013.


Clinical Trials Database



An interactive search of trials and results


Upcoming Meetings

Wednesday, January 18 2017
19th Bangkok International Symposium on HIV Medicine
Queen Sirikit National Convention Center, Bangkok, Thailand
Saturday, February 11 2017
7th International Workshop on HIV & Women
Seattle, Washington, USA